John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
How can we advance students from comprehension to prediction in physiology? Using the classic Wiggers diagram, this work demonstrates a logic-driven approach to connecting mechanistic events and supporting causal reasoning. E. P. Silldorff et al. ow.ly/NqYi51065bI
4
1
10
429
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Original Article: Prasugrel versus Ticagrelor in Acute Coronary Syndromes (SWITCH-SWEDEHEART trial) nej.md/4wGVCZd Editorial: The Emerging Role of Treatment Policy Implementation Trials in Acute Coronary Syndrome nej.md/45FxURZ #ESCCongress #Cardiology
8
29
125
23,277
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Here is a trial that needs to be repeated and finished ASAP
AF pt unsuitable for OAC? ASAP-TOO RCT of LAAC vs SAPT/no antithrombotic was underpowered due to poor accrual. No significant diff in ischemic stroke/systemic embolism. #LAAC overall low risk for complications. NEW LAAC focus issue of #JACC: bit.ly/4iJ8Mjr @bbikdeli
5
10
78
13,344
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Is โ€œmoderate drinking is good for the heartโ€ still true? New review on alcohol and cardiovascular disease: inter-organ crosstalk, microvascular dysfunction and accelerated cardiovascular ageing. Time to rethink the glass. Read more in #EHJ. doi.org/10.1093/eurheartj/ehโ€ฆ #cardiotwitter @ESC_Journals @escardio
3
48
3
141
8,866
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Looking for a practical guide to bifurcation PCI? ๐Ÿ“– The SCAI PCI for Coronary Bifurcation Lesions ebook brings together leading experts to cover: โ€ข Provisional vs. two-stent strategies โ€ข IVUS and OCT optimization โ€ข Left main bifurcation PCI โ€ข DK Crush, Culotte, TAP, and more Plus procedural technique videos demonstrating key approaches. Download for free today โžก๏ธ scai.org/publications/ebooksโ€ฆ #InterventionalCardiology #CardioX #CardioEd #PCI @DrMauricioCohen @KateKearney4 @ArasiMaran
42
172
12,273
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
In a new #ScienceReview, researchers discuss the emerging effects obesity medications, such as GLP-1-based therapies, have on cognition and brain health. Learn more: scim.ag/4k1BH4z
9
34
1
113
22,458
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Chest pain in the Emergency Department: is it the aorta? New acute aortic syndrome rule-out criteria, developed and externally validated, to safely skip CT in low-risk patients. Fewer missed dissections, fewer unnecessary scans. Read more in #EHJ. doi.org/10.1093/eurheartj/ehโ€ฆ #aorta #emergency #cardiotwitter @ESC_Journals @escardio
3
32
121
11,027
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
๐Ÿซ€ Could arterial stiffness help predict outcomes after cardiac surgery? Beyond blood pressure, arterial stiffness may impair ventricularโ€“arterial coupling and is associated with postoperative kidney injury, myocardial ischemia, heart failure and stroke. This review explores assessment methods, prognostic implications and perioperative strategies. Read more: imrpress.com/journal/RCM/27/โ€ฆ ๐Ÿ‘ฅ Authors: Fabio Anastasio, Guido Pastorini @Egocardio , Alessandro Gonella, Mauro Feola. ๐Ÿฅ Affiliations: Hospital of Mondovรฌ, Azienda Sanitaria Locale CN1 (ASLCN1). #CardiacSurgery #ArterialStiffness #Cardiology
1
3
1
11
491
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Soon none will like to go into the cathlab without having a proper Cardiac CT to fine the planning of coronary procedures. This is what happened already for Thoracic and Abdominal surgery, for Vascular Surgery/Intervention, and so forth. 3-4 decades ago CT was considered agonizing because MR was going to take over and look where we are now. โค๏ธ๐Ÿ˜„
1
1
1
17
5,285
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
How multimodal AI, combined with blood test omics via "liquid biopsies," will transform cancer monitoring and enable earliest detection. open-access @CellCellPress cell.com/cell/fulltext/S0092โ€ฆ
12
62
2
233
25,052
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
The expansion of kinase drug discovery: new targets, platforms and indications nature.com/articles/s41573-0โ€ฆ rdcu.be/58kHQSQ3Xcna This new Review analyses the kinase therapeutic landscape, covering more than 2,100 kinase-targeting agents that have entered clinical development
88
4
361
15,670
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
โœ… 4 drug classes cut HFrEF deaths: ARNI, BB, MRA, SGLT2i โ€จโŒ 30 others with great rationale failed in Phase 3 RCTs โ€จ๐Ÿ‡บ๐Ÿ‡ธ Only 18% get all 4 โ†’ ~114K US deaths preventable/yr โ€จ๐ŸŽฏ Implement GDMT with the same intensity we test new drugs โ€จ#HFrEF #CardioTwitter @HFSA @ACCinTouch
3
10
19
1,358
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Google published a paper that might end the PhD. Itโ€™s called โ€œScientistTwoโ€ For centuries, the bottleneck to human knowledge has been the human brain. It takes five years of grueling labor to read the literature, find a gap, formulate a hypothesis, run the experiments, and write the paper. But, Google automated the entire pipeline. They built an AI that reads a problem, forms hypotheses, runs experiments, writes the paper, AND simulates its own peer review. no human touches it. It reads millions of papers to find blind spots in the current science. It generates novel hypotheses. It designs the experiments. It writes the code to test them. When the code fails, it debugs itself. When the results come in, it analyzes the data, generates the charts, and writes the final academic paper. It even simulates a brutal peer-review process to critique and improve its own work before it considers the project finished. This isn't an LLM summarizing a PDF. This is a fully autonomous digital scientist. What takes a human candidate half a decade of massive intellectual effort... the AI accomplishes in a fraction of the time, at a fraction of the cost. The implications are staggering. If you can spin up 10,000 autonomous researchers overnight, the rate of scientific discovery is about to go vertical. We are moving from artisanal, human-speed research to industrialized knowledge creation. But it raises an uncomfortable reality for academia. When an AI can read the literature, design the experiment, execute the code, and write the paper... What exactly is the human supposed to do?
91
317
72
1,416
147,441
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Presented at #ScientificSessions26: In patients with atrioventricular block, left bundle-branch pacing resulted in a lower incidence of a composite of death, hospitalization for heart failure, or pacing-induced cardiomyopathy than right ventricular pacing. Full OptimPacing trial results: nej.md/4favsI9 @AHAScience
8
147
19
391
68,332
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Here is crazy that pretty much every F500 CEO is complicit in 1. They self insure - good thing 2. They hire a third party administrator that is owned by a Too Big To Care insurance company. - Really Bad 3. They allow that TPA to deny care determined by the doctors that the TPA selected to be in network - Horrifically bad 4. They donโ€™t tell the CEOs about the denied care , when itโ€™s their money and ultimately their decision as to whether they should pay for care - more horrific 5. Employees and their families get sicker while the denial is appealed. Again, when the ceo has no clue. Even if the cost to help the patient could a small amount. - insane Big self insured companies do dumb shit that makes the cost of care in this country far higher than it should be. Itโ€™s not their core competency and they often listen to consultants whose interests are not aligned with theirs.
172
354
27
2,564
814,056
Wow! Beyond 5-6 years, SAVR has a survival benefit compared to TAVR. TAVR not for the young! It complements SAVR for the elderly.
Paper out in @escardio #EHJ, lead by #milanmilojevic: time-dependent late mortality in a pooled analysis of trials TL:DR: the hazard for all-cause mortality changes at 1.9 years, with 5-7 years HR of 1.64 (p < 0.001) in favor of #SAVR @EACTS @ctsnetorg academic.oup.com/eurheartj/aโ€ฆ
46
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
Paper out in @escardio #EHJ, lead by #milanmilojevic: time-dependent late mortality in a pooled analysis of trials TL:DR: the hazard for all-cause mortality changes at 1.9 years, with 5-7 years HR of 1.64 (p < 0.001) in favor of #SAVR @EACTS @ctsnetorg academic.oup.com/eurheartj/aโ€ฆ
3
19
3
40
13,229
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
GLP-1 receptor agonists are among the most effective treatments for obesity and other metabolic disorders. With widespread use of these drugs, it has become clear that their effects go well beyond health conditions traditionally linked to metabolism, affecting multiple other organ systems, particularly the brain. Continued research in this field has also expanded beyond the GLP-1 receptor as a target, with the development of additional drugs and combinations to help optimize patient care. Learn more in this special issue of Science: scim.ag/4yX17UB
34
158
31
565
75,445
John Mannisi MD ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฎ๐Ÿ‡นโค๏ธโ€๐Ÿฉน๐Ÿƒ retweeted
New @Nature Can a smartwatch with AI accurately detect hypertension? A prospective study of 196 healthy ~40 year-old participants finds a sensitivity of 66%, specificity of 90%, comparable to a single clinic visit Still much more work to do in larger studies, older age groups, and achieving higher sensitivity and accuracy nature.com/articles/s41586-0โ€ฆ
21
35
5
172
27,200